CARR PowerFuge Pilot Separation System
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Food and Drug Administration (FDA), under the Department of Health and Human Services, has issued a Special Notice indicating an Intent to Sole Source for the acquisition of a CARR PowerFuge Pilot Separation System. This notice is published to identify any other interested and qualified sources capable of providing this specific laboratory equipment. Responses are due June 22, 2026.
Scope of Requirement
This requirement is for the procurement of a CARR PowerFuge Pilot Separation System, which falls under Product Service Code 6640 (Laboratory Equipment And Supplies). Further details regarding the specific needs and technical requirements are available in the "Notice of Intent to Sole Source" document.
Contract & Timeline
- Type: Special Notice (Notice of Intent to Sole Source)
- Set-Aside: None specified
- Response Due: June 22, 2026, at 7:00 PM ET
- Published: June 15, 2026
Purpose of Notice
This notice serves as a market research tool to determine if other sources exist that can provide the required CARR PowerFuge Pilot Separation System. If no other qualified sources are identified, the FDA intends to proceed with a sole source award.
Contact Information
For inquiries, contact Jennifer Mun at jennifer.mun@fda.hhs.gov.